Asset Details
Do you wish to reserve the book?
Effect of Plasma Exchange on Hepatitis B‐Related Acute‐On‐Chronic Liver Failure: A Cross‐Sectional Study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of Plasma Exchange on Hepatitis B‐Related Acute‐On‐Chronic Liver Failure: A Cross‐Sectional Study
Do you wish to request the book?
Effect of Plasma Exchange on Hepatitis B‐Related Acute‐On‐Chronic Liver Failure: A Cross‐Sectional Study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of Plasma Exchange on Hepatitis B‐Related Acute‐On‐Chronic Liver Failure: A Cross‐Sectional Study
2025
Overview
ABSTRACT
Background
To evaluate the effect of plasma exchange (PE) on the prognosis of patients with hepatitis B virus‐related acute‐on‐chronic liver failure (HBV‐ACLF).
Methods
The basic information (gender, age, blood type), the frequency and dosage of PE, the changes of indicators before and after PE, the adverse reactions related to PE and the prognosis of patients with HBV‐ACLF who received PE in our hospital from April 2018 to December 2021 were retrospectively analyzed.
Results
197 patients with HBV‐ACLF who underwent PE were included in the analysis. Multivariate analysis shows that blood ammonia, ALBI, bacterial infection rate, HBV‐DNA load, MELD score, etc., are independent risk factors affecting the efficacy of PE treatment in HBV‐ACLF patients before and after PE treatment.
Conclusion
There are many factors influencing the efficacy of plasma exchange in patients with HBV‐ACLF. Compared to other factors, high blood ammonia levels and high ALBI are the independent risk factors for poor short‐term efficacy of plasma exchange.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
